Article Versions Notes

Kumar D, Aggarwal N, Kumar H, Kapoor G, Deep A, Bibi S, Sharma A, Chopra H, Kumar Marwaha R, Alshammari A, et al. 2-Substituted-3-(5-Substituted-1,3,4-oxadiazol/thiadiazol-2-yl) Thiazolidin-4-one Derivatives: Synthesis, Anticancer, Antimicrobial, and Antioxidant Potential. Pharmaceuticals. 2023; 16(6):805. https://doi.org/10.3390/ph16060805

Kumar, Davinder, Navidha Aggarwal, Harsh Kumar, Garima Kapoor, Aakash Deep, Shabana Bibi, Aastha Sharma, Hitesh Chopra, Rakesh Kumar Marwaha, Abdulrahman Alshammari, and et al. 2023. "2-Substituted-3-(5-Substituted-1,3,4-oxadiazol/thiadiazol-2-yl) Thiazolidin-4-one Derivatives: Synthesis, Anticancer, Antimicrobial, and Antioxidant Potential" Pharmaceuticals 16, no. 6: 805. https://doi.org/10.3390/ph16060805

Kumar, D., Aggarwal, N., Kumar, H., Kapoor, G., Deep, A., Bibi, S., Sharma, A., Chopra, H., Kumar Marwaha, R., Alshammari, A., Alharbi, M., & Hayee, A. (2023). 2-Substituted-3-(5-Substituted-1,3,4-oxadiazol/thiadiazol-2-yl) Thiazolidin-4-one Derivatives: Synthesis, Anticancer, Antimicrobial, and Antioxidant Potential. Pharmaceuticals, 16(6), 805. https://doi.org/10.3390/ph16060805